Bio Techne reported $51.05M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Illumina USD 134M 200M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Merck EUR 659M 340M Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD -72M 297.21M Mar/2026